Indication

Haemophilus influenzae pneumonia

*Haemophilus influenzae* pneumonia is an acute lower respiratory tract infection caused by the pleomorphic, gram-negative bacterium *Haemophilus influenzae*, encompassing both encapsulated serotypes (such as type b) and nontypeable unencapsulated strains. Read more about Haemophilus influenzae pneumonia

601 drugs 183 manufacturers

Advertisement

Drugs that treat it

Common Haemophilus influenzae pneumonia therapies.

Showing 82–90 of 601 drugs

Filter & compare in the drug finder →Opens the drug finder with Haemophilus influenzae pneumonia preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Haemophilus influenzae pneumonia.

*Haemophilus influenzae* pneumonia is an acute lower respiratory tract infection caused by the pleomorphic, gram-negative bacterium *Haemophilus influenzae*, encompassing both encapsulated serotypes (such as type b) and nontypeable unencapsulated strains.

The infection predominantly affects young children, older adults, and individuals with immunocompromising conditions or underlying cardiopulmonary diseases such as chronic obstructive pulmonary disease.

Pathophysiologically, the pathogen colonizes the nasopharynx before descending into the tracheobronchial tree, inciting alveolar inflammation, purulent exudate formation, and consolidation.

Clinically, it manifests with fever, productive cough, dyspnea, and pleuritic chest pain, and it can progress to bacteremia or respiratory failure.

Personalize your experience

Follow Haemophilus influenzae pneumonia and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it